Search
Indusatumab vedotin
go.drugbank.com/drugs/DB12413InvestigationalIndusatumab vedotin has been used in trials studying the treatment of Pancreatic Adenocarcinoma, Adenocarcinoma of the Stomach, Recurrent Gastric Adenocarcinoma, Metastatic Gastric Adenocarcinoma, and
Pamufetinib
go.drugbank.com/drugs/DB20752InvestigationalThe usage of the INN stem '-tinib' in the name indicates that Pamufetinib is a tyrosine kinase inhibitor. Pamufetinib is under investigation in clinical trial NCT04999761 (AB122 Platform Study).
Acadesine
go.drugbank.com/drugs/DB04944InvestigationalAcadesine has been granted Orphan Drug Designation for B-CLL in the EU. … Acadesine (AICA-riboside) is a purine nucleoside analog with anti-ischemic properties that is currently being studied (Phase 3) for the prevention of adverse cardiovascular outcomes in patients undergoing
N-acetyl-alpha-D-glucosamine
go.drugbank.com/drugs/DB03740ExperimentalThe N-acetyl derivative of glucosamine.
Chlorophyll B
go.drugbank.com/drugs/DB04506ExperimentalIt has the atomic symbol Mg, atomic number 12, and atomic weight 24.31. … It is a component of both intra- and extracellular fluids and is excreted in the urine and feces.
KB002
go.drugbank.com/drugs/DB05194ExperimentalIt is developed for the treatment of autoimmune diseases, initially rheumatoid arthritis.
Cambinol
go.drugbank.com/drugs/DB15493ExperimentalCambinol is a beta-naphtol derivative that inhibits NAD-dependant deacetylases to reduce cell survival under stress. This activity is currently being investigated for its use as a cancer treatment.
Talactoferrin alfa
go.drugbank.com/drugs/DB05426InvestigationalIt increases body’s immune power and also works as a natural antioxidant, helping to control cell and tissue damage caused by oxidation.